Genetic regulation of androgen action

Prostate

Volumn 28, Issue 3 SUPPL. 6, 1996, Pages 45-51

  Kallio, Pekka J ^a   Palvimo, Jorma J ^a   Jänne, Olli A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

androgen receptor; response element; transcriptional regulation

Indexed keywords

ANDROGEN RECEPTOR; STEROID RECEPTOR;

CONFERENCE PAPER; GENE ACTIVATION; GENE REPRESSION; GENETIC REGULATION; HORMONAL REGULATION; HUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY MECHANISM; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0029878189     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0045(1996)6+<45::aid-pros9>3.0.co;2-j     Document Type: Conference Paper

References (46)

1. Jänne OA, Shan L-X: Structure and function of the androgen receptor. Ann NY Acad Sci 626:81-91, 1991.
2. Wolf DA, Herzinger T, Hermeking H, Blaschke D, Hörz W: Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Mol Endocrinol 7:924-936, 1993.
3. Kemppainen JA, Lane MV, Sar M, Wilson EM: Androgen receptor phosphorylation, turnover, nuclear transport and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 267:968-974.
4. LaSpada AR, Roiling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa-Petrusewicz I, Yee W-C, Fischbeck KH: Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nature Genet 2:301-304, 1992.
5. Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS: Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271-321, 1995.
6. Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G, Pinsky L: Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genet 5:184-188, 1993.
7. Kallio PJ, Poukka H, Moilanen A, Jänne OA, Palvimo JJ: Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol Endocrinol 9:1017-1028, 1995.
8. Bingham PM, Scott MO, Wang S, McPhaul MJ, Wilson EM, Garbern JY, Merry DE, Fischbeck KH: Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice. Nature Genet 9:191-196, 1995.
9. Wilson CM, McPhaul MJ: A and B forms of the androgen receptor are present in human genital skin fibroblasts. Proc Natl Acad Sci USA 91:1234-1238, 1994.
10. Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barret-Lee P, Easton DF, Ponder BAJ, Stratton MR: A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 2:132-134, 1992.
11. Lobaccaro J-M, Lumbroso S, Balon C, Galtier-Dereure F, Bringer J, Lesimple T, Namer M, Cutuli BF, Pujol H, Sultan C: Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 2:1799-1802, 1993.
12. Klocker H, Culig Z, Hobisch A, Cato ACB, Bartsch G: Androgen receptor alterations in prostatic carcinoma. Prostate 35:266-273, 1994.
13. Taplin M-E, Burley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP: Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 322:1393-1398.
14. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi O-P: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 9:401-406, 1995.
15. Roche PJ, Hoare SA, Parker MG: A consensus DNA-binding site for the androgen receptor. Mol Endocrinol 6:2229-2235, 1992.
16. Kallio PJ, Palvimo JJ, Mehto M, Jänne OA: Analysis of androgen receptor-DNA interactions with receptor proteins produced in insect cells. J Biol Chem 269:11514-11522, 1994.
17. Kasper S, Rennie PS, Bruchovsky N, Sheppard PC, Cheng H, Lin L, Shiu RPC, Snoek R, Matusik RJ: Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene. J Biol Chem 269:31763-31769, 1994.
18. Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, McQueen SA, Cheng H, Snoek R, Hamel A, Bock ME, MacDonald BS, Nickel BE, Chang C, Liao S, Cattini PA, Matusik RJ: Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol 7:23-26, 1993.
19. Greenberg NM, DeMayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M, Angelopolou R, Dodd JG, Duckworth ML, Rosen JM, Matusik RJ: The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 8:230-239, 1994.
20. Adler AJ, Danielsen M, Robins DM: Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. Proc Natl Acad Sci USA 89:11660-11663, 1992.
21. Ho K-C, Marschke KB, Tan J, Power SGA, Wilson EM, French FS: A complex response element in the intron 1 of the androgen-regulated 20-kDa protein gene displays cell type-dependent androgen receptor specificity. J Biol Chem 268:27226-27235, 1993.
22. Onate SA, Prendergast P, Wagner JP, Nissen M, Reeves R, Pettijohn DE, Edwards DP: The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol 14:3376-3391, 1994.
23. Kupfer SR, Wilson EM, French FS: Androgen and glucocorticoid receptors interact with insulin degrading enzyme. J Biol Chem 269:20622-20628, 1994.
24. Dedhar S, Rennie PS, Shago M, Hagestejn C-YL, Yang H, Filmus J, Hawlwy RG, Bruchovsky N, Cheng H, Matusik RJ, Giguère V: Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367:480-483, 1994.
25. Li Q, Wrange Ö: Translational positioning of a nucleosomal glucocorticoid response element modulates glucocorticoid receptor affinity. Genes Dev 7:2471-2482, 1993.
26. Archer TK, Lefebvre P, Wolford RG, Hager GL: Transcription factor loading on the MMTV promoter: A bimodal mechanism for promoter activation. Science 255:1573-1576, 1992.
27. Archer TK, Lee H-L, Cordingley MG, Mymryk JS, Fra-goso G, Berard DS, Hager GL: Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter. Mol Endocrinol 8:568-576, 1994.
28. Mymryk JS, Berard D, Hager GL, Archer TK: Mouse mammary tumor virus chromatin in human breast cancer cells is constitutively hypersensitive and exhibits steroid hormone-independent loading of transcription factors in vivo. Mol Cell Biol 15:26-34, 1995.
29. Yoshinaga SK, Peterson CL, Herskowitz I, Yamamoto KR: Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258:1598-1604, 1992.
30. Roeder RG: The complexities of eukaryotic transcription initiation: Regulation of preinitiation complex assembly. Trends Biochem Sci 16:402-407, 1991.
31. Tjian R, Maniatis T: Transcriptional activation: A complex puzzle with few easy pieces. Cell 77:5-8, 1994.
32. Palvimo JJ, Kallio PJ, Ikonen T, Mehto M, Jänne OA: Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation. Mol Endocrinol 7:1399-1407, 1993.
33. Ing NH, Beekman JM, Tsai SY, Tsai M-J, O'Malley BW: Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J Biol Chem 267:17617-17623, 1992.
34. MacDonald PN, Sherman DR, Dowd DR, Jefcoat SC, Delisle RK: The vitamin D receptor interacts with general transcription factor IIB. J Biol Chem 270:4748-4752, 1995.
35. Jacq X, Brou C, Lutz Y, Davidson I, Chambon P, Tora L: Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79:107-117, 1994.
36. Cavaillés V, Dauvois S, Danielian PS, Parker MG: Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91:10009-10013, 1994.
37. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD: Interaction of thyroid hormone receptor with a conserved transcriptional mediator. Nature 374:91-94, 1995.
38. Lee JW, Chois HS, Gyuris J, Brent R, Moore DD: Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol 9:243-254, 1995.
39. Pfahl M: Nuclear receptor/AP-1 interaction. Endocr Rev 14:651-658, 1993.
40. Chen J-Y, Penco S, Ostrowski J, Balaguer P, Pons M, Starrett JE, Reczek P, Chambon P, Gronemeyer H: RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J 14:1187-1197, 1995.
41. Shemshedini L, Knauthe R, Sassone-Crosi P, Pornon A, Gronemeyer H: Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO J 10:3839-3849, 1991.
42. Kushner PJ, Baxter JD, Duncan K-G, Lopez GN, Scaufele F, Uht RM, Webb P, West BL: Eukaryotic regulatory units lurking in plasmid DNA: The activator protein-1 site in pUC. Mol Endocrinol 8:405-407, 1994.
43. Ray A, Prefontaine KE: Physical association and func-tional antagonism between the p65 subunit of transcription factor NK-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752-756, 1994.
44. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Jr: Characterization of mechanisms involved in transrepression of NK-κB by activated glucocorticoid receptors. Mol Cell Biol 15:943-953, 1995.
45. Trapp T, Rupprecht R, Castrén M, Reul JMHM, Hols-boer F: Heterodimerization between mineralocorticoid and glucocorticoid receptor: A new principle of glucocorticoid action in the CNS. Neuron 13:1-20, 1994.
46. Aronica SM, Kraus WL, Katzenellenbogen BS: Estrogen action via the cAMP signalling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521, 1994.